Wunchana Seubwai
Khon Kaen, 40002, Thailand
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 68 publications
System-level multi-omics uncover proteomic, peptidomic, and metabolic remodeling in Microcystin-LR exacerbated chronic kidney disease.
Journal: Ecotoxicology and environmental safety
Published: January 29, 2026
Detection of Serum Tumor-Associated Glycobiomarker for Meningioma Using Dolichos biflorus Agglutinin.
Journal: Journal of proteome research
Published: November 18, 2025
Integrated transcriptomic and molecular docking analysis identifies Rhotekin 2 as a promising therapeutic target for overcoming gemcitabine resistance in cholangiocarcinoma.
Journal: Biomedical reports
Published: June 17, 2025
Molecular Mechanisms of Gemcitabine Resistance in Cholangiocarcinoma.
Journal: Oncology research
Published: June 12, 2025
Pro-Tumorigenic Roles of Cyclin Dependent Kinase 2 and its Associated Cyclins in Cholangiocarcinoma Progression under High Glucose Condition.
Journal: Archives of medical research
Published: May 14, 2025
Serum N-Glycomics with Nano-LC-QToF LC-MS/MS Reveals N-Glycan Biomarkers for Glioblastoma, Meningioma, and High-Grade Meningioma.
Journal: Journal of proteome research
Published: February 05, 2025
Silencing of O-GlcNAc Transferase Attenuated O-GlcNAcylation and Metastatic Potentials of Melanoma Cells Through Suppression of Akt-NFκB Signaling Pathway.
Journal: Chembiochem : a European journal of chemical biology
Published: October 29, 2024
High cyclic GMP-AMP synthase and stimulator of interferon genes in cholangiocarcinoma suggest their potential as targets for treatment.
Journal: PeerJ
Published: October 15, 2024
Targeting EGFR Activation to Overcome Gemcitabine Resistance in Cholangiocarcinoma.
Journal: Anticancer research
Published: October 03, 2024
Bioinformatics analysis identified TCP1 and NOTCH1 as potential target molecules to overcome 5-fluorouracil resistance in cholangiocarcinoma.
Journal: Advances in clinical and experimental medicine : official organ Wroclaw Medical University
Published: September 26, 2024
Identification of IGFBP3 and LGALS1 as potential secreted biomarkers for clear cell renal cell carcinoma based on bioinformatics analysis and machine learning.
Journal: Advances in clinical and experimental medicine : official organ Wroclaw Medical University
Published: June 27, 2024
FABP7: A Potential Diagnostic and Prognostic Biomarker for Clear Cell Renal Cell Carcinoma.
Journal: In vivo (Athens, Greece)
Published: June 13, 2024
Last Updated: 09/26/2026